|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 7115 |
FusionGeneSummary for CHMP4B_FBXO34 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CHMP4B_FBXO34 | Fusion gene ID: 7115 | Hgene | Tgene | Gene symbol | CHMP4B | FBXO34 | Gene ID | 128866 | 55030 |
| Gene name | charged multivesicular body protein 4B | F-box protein 34 | |
| Synonyms | C20orf178|CHMP4A|CTPP3|CTRCT31|SNF7|SNF7-2|Shax1|VPS32B|Vps32-2|dJ553F4.4 | CGI-301|Fbx34 | |
| Cytomap | 20q11.22 | 14q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | charged multivesicular body protein 4bSNF7 homolog associated with Alix 1Snf7 homologue associated with Alix 1chromatin modifying protein 4Bchromatin-modifying protein 4bhSnf7-2hVps32-2vacuolar protein-sorting-associated protein 32-2 | F-box only protein 34protein CGI-301 | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | Q9H444 | Q9NWN3 | |
| Ensembl transtripts involved in fusion gene | ENST00000217402, | ENST00000313833, ENST00000555087, ENST00000440021, | |
| Fusion gene scores | * DoF score | 8 X 4 X 6=192 | 5 X 5 X 2=50 |
| # samples | 11 | 5 | |
| ** MAII score | log2(11/192*10)=-0.803602787196497 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/50*10)=0 | |
| Context | PubMed: CHMP4B [Title/Abstract] AND FBXO34 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CHMP4B | GO:0039702 | viral budding via host ESCRT complex | 24878737 |
| Hgene | CHMP4B | GO:0051260 | protein homooligomerization | 18209100 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BU624572 | CHMP4B | chr20 | 32399341 | - | FBXO34 | chr14 | 55766161 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000217402 | ENST00000313833 | CHMP4B | chr20 | 32399341 | - | FBXO34 | chr14 | 55766161 | + |
| 5CDS-intron | ENST00000217402 | ENST00000555087 | CHMP4B | chr20 | 32399341 | - | FBXO34 | chr14 | 55766161 | + |
| 5CDS-intron | ENST00000217402 | ENST00000440021 | CHMP4B | chr20 | 32399341 | - | FBXO34 | chr14 | 55766161 | + |
Top |
FusionProtFeatures for CHMP4B_FBXO34 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CHMP4B | FBXO34 |
| Probable core component of the endosomal sortingrequired for transport complex III (ESCRT-III) which is involvedin multivesicular bodies (MVBs) formation and sorting of endosomalcargo proteins into MVBs. MVBs contain intraluminal vesicles(ILVs) that are generated by invagination and scission from thelimiting membrane of the endosome and mostly are delivered tolysosomes enabling degradation of membrane proteins, such asstimulated growth factor receptors, lysosomal enzymes and lipids.The MVB pathway appears to require the sequential function ofESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostlydissociate from the invaginating membrane before the ILV isreleased (PubMed:12860994, PubMed:18209100). The ESCRT machineryalso functions in topologically equivalent membrane fissionevents, such as the terminal stages of cytokinesis(PubMed:21310966). Together with SPAST, the ESCRT-III complexpromotes nuclear envelope sealing and mitotic spindle disassemblyduring late anaphase (PubMed:26040712). Plays a role in theendosomal sorting pathway. ESCRT-III proteins are believed tomediate the necessary vesicle extrusion and/or membrane fissionactivities, possibly in conjunction with the AAA ATPase VPS4. Whenoverexpressed, membrane-assembled circular arrays of CHMP4Bfilaments can promote or stabilize negative curvature and outwardbudding. CHMP4A/B/C are required for the exosomal release ofSDCBP, CD63 and syndecan (PubMed:22660413).{ECO:0000269|PubMed:12860994, ECO:0000269|PubMed:18209100,ECO:0000269|PubMed:21310966, ECO:0000269|PubMed:22660413,ECO:0000269|PubMed:26040712}. (Microbial infection) The ESCRT machinery also functionsin topologically equivalent membrane fission events, such as thebudding of enveloped viruses (HIV-1 and other lentiviruses). Viaits interaction with PDCD6IP involved in HIV-1 p6- and p9-dependent virus release. {ECO:0000269|PubMed:14505569,ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844,ECO:0000269|PubMed:22422861}. | Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHMP4B_FBXO34 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHMP4B_FBXO34 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHMP4B_FBXO34 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHMP4B_FBXO34 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CHMP4B | C1854311 | Cataract, posterior polar, 3 | 1 | CTD_human;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|